Skip to content

TAK - TAKEDA PHARMACEUTICAL CO LTD - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchT

Takeda Pharmaceutical Co Ltd ADR

TAK · NYSE

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

T

TAKTakeda Pharmaceutical Co Ltd ADR

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $18.90
52-wk low: $12.78
Prev close: $17.08
Mkt cap: $58.57B
Fwd P/E: 11.1x
Beta: 0.10

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$375.6M

JS
Jim Simons
Q2 2026 13F
$41.2M
position
QR
Qube Research
Q2 2026 13F

Earnings

Reported Jul 30, 2026

Earnings came in 17.1% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -3.5%
Forward P/E: 11.14
Market cap: $58.6B

Valuation

P/S0.01
P/B1.21
Dividend yield3.4%

Quality

Operating margin16.5%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: TAK
Exchange: NYSE
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $58.57B
Beta: 0.10

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Div yield

3.42%

P/S

0.0x

P/B

1.2x

Profit margin

-3.5%

Op margin

+16.5%

ROE

-2.3%

$35.4M

position

DS

D.E. Shaw

Q2 2026 13F

$32.9M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for TAK

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

$0.48+17.1%

$0.41 expected

Next report

What the street expects next

Revenue expected

$1.16T

6 analysts

ROE-2.3%

ROA2.7%

Growth

Beta0.10